Forbes Tech A Turning Point For Gene Therapy: What One Tragic Event Reveals About The Promise And Peril Of Genetic Medicine
A patient death in a CRISPR trial halts gene editing studies, raising critical safety questions. What this means for the future of genetic medicine and patient care.